Browsing by Subject "consciousness disorder"

Now showing 1 - 4 of 4
  • No Thumbnail Available
    Item
    Frontal sinus osteoma complicated with intracranial inflammatory polyp: A case report and review of the literature
    (2009) Umura S.; Gunhan K.; SonguM; Temiz C.; YuceturkAV
    Background: Osteomas of the paranasal sinuses rarely cause intracranial manifestations. A neurological symptom may be the first sign of a previously unrecognized osteoma. Case description: A 28-year-old male was referred with one episode of witnessed tonic-clonic seizure and loss of consciousness. Radiologic examination revealed a calcific mass in the frontal sinus and a cystic structure was detected in the posterior component of the lesion. The patient underwent a combined nasal endoscopic approach and a bilateral frontal osteoplastic craniotomy. The ossifying tumoral tissue and the polypoid soft tissue mass were removed. The histo-pathologic diagnosis of the hard, bony tumor was consistent with an osteoma and the polypoid soft tissue was an inflammatory polyp. Conclusion: This case report illustrates a rare and life threatening complication of a frontal sinus osteoma with an intracranial extension of an inflammatory polyp.
  • No Thumbnail Available
    Item
    Alcohol withdrawal delirium like neuroleptic malignant syndrome: Intensive care case report; [Yoǧun bakim olgu sunumu: Nöroleptik malign sendrom benzeri alkol yoksunluk deliryumu]
    (2009) Akyürekli O.; Selçuki D.
    Background: Heavy drinkers who suddenly decrease their alcohol consumption or abstain completely may experience in hours or days alcohol withdrawal delirium. Symptoms may include the following:Autonomic hiperactivity, tremors,insomnia,transient hallucinations (auditory, visual, or tactile), nausea/vomiting, anxiety or agitation and grand mal seizures. Case: A 36 years old,woman,married,have two child,housewife,African-British patient suffered clouded conciousness, hyperthermia,tremors all around the body.First exemination of patient in emergency department established clouded conciousness, widespread rigidity and tremors all around the body, hyperthermia (40 C degrees),tachycardia,sweating, hypertension, visual hallucinations, leukocytosis,increasing of creatine kinase rates more than 200 equal amount, hypokalemia,increasing of liver enzymes. With this findings and neuroleptic intake doubt patient hospitalized for further exemination and treatment. Conclusion: Alcohol withdrawal delirium must be identified because it is accompanied by substantial mortality. Anamnesis and investigation should be sufficient for differential diagnosis. This case diagnosed as neuroleptic malignant syndrome after first exemination. After the detailing exemination diagnosis changed to alcohol withdrawal delirium.We made the differential diagnosis and inspected the case with help of the literature.
  • No Thumbnail Available
    Item
    Wernicke's encephalopathy in a child with Down syndrome, undergoing treatment for acute lymphoblastic leukemia
    (Blackwell Publishing, 2016) Yıldırım A.T.; Bilgili G.; Akman B.; Ovalı G.Y.; Özgüven A.A.; Gülen H.
    [No abstract available]
  • No Thumbnail Available
    Item
    Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study
    (John Wiley and Sons Inc, 2023) Guzelkucuk Z.; Karapınar D.Y.; Gelen S.A.; Tokgoz H.; Ozcan A.; Ay Y.; Bahadır A.; Ozbek N.Y.; Oren A.C.; Ayhan A.C.; Akyay A.; Akıncı B.; Karadas N.; Unuvar A.; Oren H.; Fettah A.; Kaya Z.; Isık B.; Eker İ.; Karaman S.; Yıldırım A.T.; Orhan M.F.; Oymak Y.; Timur C.; Yazici N.; Simsek A.; Karakurt N.; Toret E.; Evim M.S.
    Background: In patients with acute lymphoblastic leukemia (ALL), the risk of thromboembolism increases due to hemostatic changes secondary to the primary disease and due to treatment-related factors. In this multicenter study, we aimed to research the frequency of central nervous system (CNS) thrombosis occurring during treatment, hereditary and acquired risk factors, clinical and laboratory features of patients with thrombosis, treatment approaches, and thrombosis-related mortality and morbidity rates in pediatric ALL patients. Procedure: Pediatric patients who developed CNS thrombosis during ALL treatment from 2010 to 2021 were analyzed retrospectively in 25 different Pediatric Hematology Oncology centers in Türkiye. The demographic characteristics of the patients, symptoms associated with thrombosis, the stage of the leukemia treatment during thrombosis, the anticoagulant therapy applied for thrombosis, and the final status of the patients recorded through electronic medical records were determined. Results: Data from 70 patients with CNS thrombosis during treatment, out of 3968 pediatric patients with ALL, were reviewed. The incidence of CNS thrombosis was 1.8% (venous: 1.5 %; arterial: 0.03%). Among patients with CNS thrombosis, 47 had the event in the first 2 months. Low molecular weight heparin (LMWH) was the most commonly used treatment with a median of 6 months (min–max: 3–28 months). No treatment-related complications occurred. Chronic thrombosis findings occurred in four patients (6%). In five (7%) patients who developed cerebral vein thrombosis, neurological sequelae (epilepsy and neurological deficit) remained. One patient died related to thrombosis, and the mortality rate was 1.4%. Conclusion: Cerebral venous thrombosis and, less frequently, cerebral arterial thrombosis may develop in patients with ALL. The incidence of CNS thrombosis is higher during induction therapy than during other courses of treatment. Therefore, patients receiving induction therapy should be monitored carefully for clinical findings suggestive of CNS thrombosis. © 2023 Wiley Periodicals LLC.